GW Pharma Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company with a license to cultivate cannabis in the UK. True pioneers, they are the producers of Sativex and Epiodiolex, the former being the world’s first prescription medicine derived from the cannabis plant —…
Cannabis Unclear licensing rules raise concerns that big foreign firms applying for patents might squeeze out local players and drive up the cost of cannabis-derived medical products. Last week, Thailand’s National Legislative Assembly (NLA) passed a bill allowing the use of cannabis and kratom, a local plant with opioid properties…
USA With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to medical cannabis? The US National Football League (NFL) is a juggernaut. Even with decreased television ratings in 2017, the league’s revenue was up. Each of the NFL’s…
South Korea Southeast Asia’s notoriously strict anti-cannabis laws could be set to relax dramatically as South Korea becomes the first country in the region to legalise cannabis for medicinal use. This surprising move towards legalisation is intended to expand treatment options for patients suffering from rare diseases such as epilepsy. …
Portugal Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of the health sector. Here she examines Portugal’s new regulatory framework on cannabis for medicinal purposes. What will actually change considering that in Portugal (and in the European Union) it is already possible to obtain a marketing…
Canada John Fowler founded 7ACRES, a licensed producer of cannabis, in 2013. In 2014, 7ACRES went over to become part of The Supreme Cannabis Company, which today stands as a unique business model in the Canadian medical cannabis sector. Indeed, The Supreme Cannabis Company operates as a wholesaler, a decision…
Canada Mark Ware, the Chief Medical Officer of Canopy Growth Corporation, has intensely investigated the effects of cannabinoids, making him perfectly placed to cover this new era of cannabis in healthcare. I propose that the renaissance of cannabis under varying regulatory frameworks actually represents a paradigm shift in health care, and…
Cannabis The opioid epidemic has reached new heights of late, claiming an estimated 40,000 American lives every year. The highly addictive nature of opium-derived medicine is the cause of the rising number of overdoses in the US and Canada. There are companies out there that are working to manufacture a new…
Cannabis Following the death penalty handed to Muhammad Lukman, a 29-year old man who was convicted of possessing, processing and distributing medicinal cannabis oil, public outcry has caused Malaysian officials to reconsider the punishment. Muhammad Lukman was arrested in 2015 for possessing 3.1 litres of cannabis oil, 279 g of compressed cannabis and 1.4 kg of…
Cannabis Canadian medical cannabis company Tilray’s stock surged by over 77 percent in the first three trading days of last week before dropping dramatically by 47.9 percent to close out the week. The US Drug Enforcement Administration’s decision to allow the company to import cannabis into the USA for medical research…
Cannabis In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the cultivation and provision of medical cannabis. The Republic will grant two 15-year licenses to private medical cannabis cultivators to…
Cannabis Founded in 1998, GW Pharmaceuticals is a true pioneer in cannabinoid medicines and the only pharmaceutical company with a license to cultivate cannabis in the UK. “While people were wary of cannabis, they became very aware that it was treating patients with severe conditions, where other medicines had either failed…
See our Cookie Privacy Policy Here